Notice of Amendment: Prescription Drug List (PDL): Epinephrine (topical solution)
The purpose of this Notice of Amendment is to notify that Health Canada will add Epinephrine topical solution for hemostasis when sold at a concentration equal to or greater than 1 mg/ml (1:1000) to the Prescription Drug List (PDL). Both the Human and the Veterinary parts of the PDL were revised.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-10-29
Data overview
- Formats
- HTML
- File languages
- English, French